Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
7.93
-0.04 (-0.56%)
At close: Feb 4, 2026, 4:00 PM EST
7.90
-0.02 (-0.32%)
After-hours: Feb 4, 2026, 4:04 PM EST

Lifecore Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jun - May.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 May '25 May '24 May '23 May '22 May '21
297249172241291351
Market Cap Growth
23.77%44.93%-28.69%-17.27%-17.12%12.76%
Enterprise Value
417419305395424566
Last Close Price
7.976.725.627.949.8711.97
PE Ratio
--14.29---
Forward PE
--25.55---
PS Ratio
2.151.931.342.332.623.48
PB Ratio
220.895.253.196.863.311.73
P/TBV Ratio
----4.172.45
P/OCF Ratio
--667.99--21.32
PEG Ratio
-1.901.901.901.901.90
EV/Sales Ratio
3.243.252.373.823.815.61
EV/EBITDA Ratio
--397.55-29.8269.55
EV/EBIT Ratio
-----192.89
Debt / Equity Ratio
2.762.762.393.211.711.07
Debt / EBITDA Ratio
--101.44-9.6321.03
Asset Turnover
0.520.520.510.390.290.19
Inventory Turnover
2.452.452.141.961.460.96
Quick Ratio
1.461.461.021.230.220.42
Current Ratio
2.842.842.092.390.661.46
Return on Equity (ROE)
-76.41%-76.41%20.97%-104.52%-10.65%-10.80%
Return on Assets (ROA)
-3.04%-3.04%-1.77%-4.67%-0.55%0.35%
Return on Invested Capital (ROIC)
-7.01%-6.98%-4.66%-10.79%-1.05%0.67%
Return on Capital Employed (ROCE)
-5.70%-5.70%-3.30%-9.20%-3.50%0.70%
Earnings Yield
-15.05%-15.56%7.00%-41.36%-40.11%-9.20%
FCF Yield
-4.62%-5.47%-10.56%-16.17%-18.05%-2.49%
Buyback Yield / Dilution
5.02%5.02%-22.36%-1.67%-0.59%-0.45%
Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q